Global Healthcare CRO Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Healthcare CRO Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Contract research organizations (CROs) have transformed the way research are conducted by several pharmaceutical, biotechnology, and medical devices companies in ways more than one. These organizations offer a variety of services such as biopharmaceutical development, clinical trials conduct and other endeavors, drug discovery activities, product commercialization, assay development, and pharmacovigilance. The intensifying demand for new therapies and devices has mounted pressures on research and development (R&D) budgets of these organizations.
Healthcare CRO report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Healthcare CRO market is projected to reach US$ 62340 million in 2034, increasing from US$ 42030 million in 2022, with the CAGR of 5.7% during the period of 2024 to 2034. Demand from Biopharmaceutical Companies and Academic and Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Healthcare CRO industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Healthcare CRO key companies include Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development, PAREXEL International, ICON plc, PRA Health Sciences, InVentiv Health, Charles River Laboratories and INC Research Holdings, etc. Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development are top 3 players and held % share in total in 2022.
Healthcare CRO can be divided into Early Phase Development, Clinical Research, Laboratory and Consulting Services, etc. Early Phase Development is the mainstream product in the market, accounting for % share globally in 2022.
Healthcare CRO is widely used in various fields, such as Biopharmaceutical Companies, Academic and Research Institutes and Others,, etc. Biopharmaceutical Companies provides greatest supports to the Healthcare CRO industry development. In 2022, global % share of Healthcare CRO went into Biopharmaceutical Companies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Healthcare CRO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Quintiles Transnational Holdings
Laboratory Corporation Of America Holdings
Pharmaceutical Product Development
PAREXEL International
ICON plc
PRA Health Sciences
InVentiv Health
Charles River Laboratories
INC Research Holdings
Wuxi PharmaTech
Segment by Type
Early Phase Development
Clinical Research
Laboratory
Consulting Services
Biopharmaceutical Companies
Academic and Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Healthcare CRO market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Healthcare CRO introduction, etc. Healthcare CRO Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Healthcare CRO market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Healthcare CRO report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Healthcare CRO market is projected to reach US$ 62340 million in 2034, increasing from US$ 42030 million in 2022, with the CAGR of 5.7% during the period of 2024 to 2034. Demand from Biopharmaceutical Companies and Academic and Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Healthcare CRO industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Healthcare CRO key companies include Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development, PAREXEL International, ICON plc, PRA Health Sciences, InVentiv Health, Charles River Laboratories and INC Research Holdings, etc. Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, Pharmaceutical Product Development are top 3 players and held % share in total in 2022.
Healthcare CRO can be divided into Early Phase Development, Clinical Research, Laboratory and Consulting Services, etc. Early Phase Development is the mainstream product in the market, accounting for % share globally in 2022.
Healthcare CRO is widely used in various fields, such as Biopharmaceutical Companies, Academic and Research Institutes and Others,, etc. Biopharmaceutical Companies provides greatest supports to the Healthcare CRO industry development. In 2022, global % share of Healthcare CRO went into Biopharmaceutical Companies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Healthcare CRO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Quintiles Transnational Holdings
Laboratory Corporation Of America Holdings
Pharmaceutical Product Development
PAREXEL International
ICON plc
PRA Health Sciences
InVentiv Health
Charles River Laboratories
INC Research Holdings
Wuxi PharmaTech
Segment by Type
Early Phase Development
Clinical Research
Laboratory
Consulting Services
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Healthcare CRO market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Healthcare CRO introduction, etc. Healthcare CRO Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Healthcare CRO market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices